4Hamilton SR, Smith RL, Cameron JL. Prevalence and characters of Barrett' s esophagus in patients with adenocarcinoma of the esophagus or esophagugastric junction[J]. Hum Pathol, 1998,19:942- 948.
5Clark GE, Smyrk TC, Burdiles P, Is Barrett' s metlaplasia the source of adenocarcinomas of the cardia [J].Arch Surg, 1994, 129:609 - 614.
6Solaymani - Dodaran M, Logan RF, West J, et al . Risk of oesophageal cancer in Barrett' s oesophagus and gastrol - esophageal reflux [J]. Gut, 2004,53 : 1 070 1 074.
7Ormsby AH, Goldblum JR, Rice TW, et al . Cytokeratin subsets can reliably distinguish Barrrett's esophagus from intestinal metaplasia of the stomach [J].Hum Pathol, 1999,30: 288 - 294.
8Sergey V. Litvinov, Maarten Balzar, Manon J. Winter, et al . Epithelial Cell Adhesion Molecule (EpCAM) Modulates Cell- Cell Interactions Mediated by Classic Cadherins[J]. Cell Biol, 1997,1 337 - 1 348.
9Endlicher E , Rummele P, Beer S, et al . Barrett' s esophagus: a discrepancy between macroscopic and histological diagnosis [J]. Endoscopy, 2005, 37:1 131- 1 135.
10N A C S Wong, B F Warren, J Piris, et al . EpCAM and gpA33 are markets of Barrett' s metaplasia[J].Clin Pathol, 2006,59: 260 - 263.
